HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors

International Journal of Cancer

Volumn 110, Issue 3, 2004, Pages 459-461

  Kleiman, Anna ^a   Senyuta, Natalia ^a   Tryakin, Alexey ^a   Sauter, Marlies ^b   Karseladze, Apollon ^a   Tjulandin, Sergei ^a   Gurtsevitch, Vladimir ^a   Mueller Lantzsch, Nikolaus ^b  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^b Abteilung Virologie   (Germany)

Author keywords

Antibodies to HERV K Gag and Env; Germ cell tumor; Human endogenous retrovirus K

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GAG PROTEIN; STRUCTURAL PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL FEATURE; DIAGNOSTIC VALUE; GERM CELL TUMOR; HERV K VIRUS; HML 2 VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; RETROVIRUS; TREATMENT OUTCOME; VIRUS EXPRESSION;

ANTIBODIES; ANTIBODIES, VIRAL; BLOTTING, WESTERN; DISEASE PROGRESSION; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE THERAPY; HUMANS; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PROVIRUSES; TIME FACTORS; VIRAL PROTEINS;

EID: 2442595893     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11649     Document Type: Article

References (5)

1. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996;93:5177-84.
2. Sauter M, Schommer S, Kremmer E, Remberger K, Doelken G, Lemm I, Buck M, Best B, Neumann-Haefelin D, Mueller-Lantzsch N. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 1995;60: 414-21.
3. Altman DG. Practical statistics for medical research. New York: Chapman and Hall, 1991.
4. Sauter M, Roemer K, Best B, Afting M, Schommer S, Seitz G, Hartmann M, Mueller-Lantzsch N. Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res 1996;56:4362-5.
5. Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 1997;71:4581-8.